With a toddler at day care, a newborn at home and an RSV season around the corner, enrolling in a Telethon Kids RSV study was a no brainer for Perth Mum Jessica Fitzpatrick.
Having already taken part in Telethon Kids research with her older child, Austin, Jessica was keen to contribute further.
“When I was pregnant with Austin, I was part of a Telethon Kids study that tested whether vaccinated women pass on their antibodies. That meant I was protected in pregnancy and Austin was protected over his first winter,” Jessica said.
Her second baby, George, is now helping researchers find answers to RSV.
“Our friends’ son was hospitalised twice with RSV when he was a baby so we know the effect it can have – we’ll do what we can to protect George from that,” Jessica said.
As someone who works in a medical field, I understand the benefits of early vaccination. It’s a win-win situation – we’re protecting George and playing a part in helping other newborn babies avoid serious illnesses in the future
The study George is enrolled in will determine whether a monoclonal antibody treatment specific for RSV, given as a single injection, will protect babies for five months over the winter season. Already shown to protect preterm babies, it is now being evaluated in babies born at term.